APPEF:OTC-Appen Limited (USD)

COMMON STOCK | | OTC

Last Closing Price

USD 25.75

Change

0.00 (0.00)%

Market Cap

USD 3.70B

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Appen Limited, together with its subsidiaries, provides data solutions and services for machine learning and artificial intelligence applications for technology companies, auto manufacturers, and government agencies in Australia, the United States, and internationally. It operates through two divisions, Relevance and Speech and Image. The Relevance division offers annotated data used in search technology embedded in Web, e-commerce, and social engagement for enhancing relevance and accuracy of search engines, social media applications, and e-commerce. The Speech and Image division provides annotated speech, natural language, and image data used in speech and image recognizers, machine translation, speech synthesizers, and other machine-learning technologies. The company was formerly known as Appen Holdings Pty Limited and changed its name to Appen Limited in October 2014. Appen Limited was founded in 1996 and is headquartered in Chatswood, Australia.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-12-01 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BTHI Big Time Holdings, Inc

N/A

USD151.65B N/A N/A
HENOF Henkel AG & Co. KGaA

N/A

USD44.00B 15.83 N/A
SEMHF Siemens Healthineers AG

N/A

USD43.74B 30.16 N/A
DFIFF Diamond Fields Resources Inc

+0.02 (+22.67%)

USD43.14B 39.43 N/A
YACAF Yancoal Australia Ltd

N/A

USD41.57B 0.20 N/A
HDALF Haidilao International Holding..

N/A

USD37.30B 79.20 N/A
MQBKY Macquarie Group Limited

+2.06 (+2.02%)

USD37.00B 22.18 8.17
PETFF PTT Public Company Limited

N/A

USD34.53B 14.15 0.17
WXIBF WuXi Biologics (Cayman) Inc

N/A

USD33.35B 593.75 31.62
SARTF Sartorius Aktiengesellschaft

N/A

USD31.43B 114.64 N/A

ETFs Containing APPEF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification ()
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 68.85% N/A N/A 79% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.85% N/A N/A 79% C+
Trailing 12 Months  
Capital Gain 84.59% N/A N/A 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.59% N/A N/A 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.36% N/A N/A 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.36% N/A N/A 42% F
Risk Return Profile  
Volatility (Standard Deviation) 6.37% N/A N/A 95% A
Risk Adjusted Return 21.31% N/A N/A 56% F
Market Capitalization 3.70B N/A N/A 80% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
()
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 61.90 N/A N/A 11% F
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 54.92 N/A N/A 3% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 9.35% N/A N/A 72% C-
Return on Invested Capital 17.85% N/A N/A 82% B-
Return on Assets 6.18% N/A N/A 89% B+
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.27 N/A N/A 35% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike